Impact of personality traits, anxiety, depression and hopelessness levels on quality of life in the patients with breast cancer
Erdoğan, Zeynep İyigün
İlgün, Ahmet Serkan
Pilavcı, Kezban Nur
MetadataShow full item record
Citationİzci F, Sarsanov D, İyigün Erdoğan Z, İlgün AS, Çelebi E, Alço G, Kocaman N, Ordu Ç, Öztürk A, Duymaz T, Pilavcı KN, Elbüken F, Ağaçayak F, Aktepe F, Ünveren G, Özdem G, Eralp Y, Özmen V. Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer. Eur J Breast Health 2018; 14: 105-111.
Objective: The aim of this study was to investigate the impacts of personality traits, anxiety, depression and hopelessness levels on quality of life in the patients with breast cancer. Materials and methods: The study was performed on 90 patients diagnosed with breast cancer and 90 healthy women. Sociodemographic and Clinical Data Collection Form designed by us, Beck Hopelessness Scale (BHS), Beck Anxiety Scale (BAS), Beck Depression Scale (BDS), Eysenck Personality Inventory (EPI) and Quality of Life Scale–Short Form (SF-36) were administered to patients and to control group. Results: The patients with breast cancer were found to indicate higher levels of anxiety and depression, lower levels of quality of life, and higher scores of personality inventory subscales as compared to the healthy control group. In the patient group, it was identified that the quality of life subscale scores were found to be negatively correlated with anxiety, depression, hopelessness and neurotic personality scores; there was a positive correlation between neurotic personality scores and depression, anxiety and hopelessness scores. Conclusions: It can be concluded that the breast cancer patients with extraversion personality traits have lower levels of anxiety and depression, keeping their quality of life better, whereas the patients with higher neuroticism scores may have more impaired quality of life. Therefore, the psychiatric evaluation of the breast cancer patients during and after the treatment cannot be ruled out.